Female sex was associated with distinct baseline cardiac phenotypes but comparable left ventricular reverse remodeling and long-term clinical outcomes compared to males post-TAVI.
Cohort (n=977)
Do females and males with severe aortic stenosis undergoing TAVI have different left ventricular remodeling and long-term clinical outcomes?
Despite presenting with distinct baseline cardiac phenotypes, males and females with severe aortic stenosis experience comparable left ventricular reverse remodeling and long-term clinical outcomes following TAVI.
Background Sex-related differences in left ventricular (LV) remodeling in response to severe aortic stenosis (AS) and post-transcatheter aortic valve implantation (TAVI) remain unclear. Previous studies have demonstrated inconsistent and discordant findings regarding the relationships between LV remodeling and clinical endpoints across sexes following TAVI. More importantly, it has been shown that females with severe AS are often diagnosed later and less likely to be referred for TAVI. Objectives We sought to evaluate sex-based differences in LV remodeling prior to and after TAVI, and to assess whether these differences were associated with long-term clinical outcomes. Methods We conducted a retrospective study of 977 patients with severe AS undergoing TAVI (2013–2020). Serial echocardiograms were performed at baseline (before TAVI) and at various timepoints post-TAVI. Echocardiographic parameters related to LV remodeling were extracted. Clinical outcomes (myocardial infarction MI, heart failure hospitalization HFH, stroke, and survival) were tracked over 10 years. Results Compared with males, females had larger baseline indexed LV end-diastolic dimension (26.5 ± 4.0 mm/m2 vs. 25.3 ± 3.5; p < 0.001), lower LV mass indexLVMI (101.5 ± 28.0 vs. 111.5 ± 30.1 g/m2; p < 0.001), higher left ventricular ejection fraction (59.5 ± 11.13 vs. 53.8 ± 13.5%; p < 0.001), and higher LV filling pressures as indicated by a higher E/e’ (18.7 ± 6.9 vs. 15.6 ± 6.2, p < 0.001). However, changes in LVMI, LV chamber size, and diastolic parameters post-TAVI were similar across sexes. Within-group analyses demonstrated that both males and females experienced favorable reverse remodeling in LV mass, LVMI, and wall thicknesses post-TAVI. No significant sex differences were observed in MI, HFH, stroke, or survival post-TAVI. Conclusion Our results support that males and females present with distinct baseline cardiac phenotypes in the setting of severe AS, but both sexes experience comparable LV reverse remodeling and clinical outcomes post-TAVI. This reinforces the structural and prognostic benefit from TAVI across sexes, underscoring the importance of equitable referral and access to this intervention.
Chai et al. (Wed,) conducted a cohort in severe aortic stenosis (n=977). Female sex vs. Male sex was evaluated on Left ventricular remodeling and clinical outcomes (myocardial infarction, heart failure hospitalization, stroke, and survival). Female sex was associated with distinct baseline cardiac phenotypes but comparable left ventricular reverse remodeling and long-term clinical outcomes compared to males post-TAVI.